Identification of immune responses against aldehyde-modified peptide sequences in apoB associated with cardiovascular disease. - Wikidata - wikimedia - TriplyDB

Identification of immune responses against aldehyde-modified peptide sequences in apoB associated with cardiovascular disease.

Identification of immune responses against aldehyde-modified peptide sequences in apoB associated with cardiovascular disease.

http://www.wikidata.org/entity/Q31135767

about

T cells in atherosclerosis CD8+ T cells mediate the athero-protective effect of immunization with an ApoB-100 peptide Once Upon a Time: The Adaptive Immune Response in Atherosclerosis--a Fairy Tale No More Model IgG monoclonal autoantibody-anti-idiotype pair for dissecting the humoral immune response to oxidized low density lipoprotein Vaccine against arteriosclerosis: an update.Immunomodulation of vascular diseases: atherosclerosis and autoimmunity Inhibition of T cell response to native low-density lipoprotein reduces atherosclerosis High levels of IgM against methylglyoxal-modified apolipoprotein B100 are associated with less coronary artery calcification in patients with type 2 diabetes.Malondialdehyde-acetaldehyde adduct is the dominant epitope after MDA modification of proteins in atherosclerosis Circulating autoantibodies against the apolipoprotein B-100 peptides p45 and p210 in relation to the occurrence of carotid plaques in 64-year-old women.Vaccination to modulate atherosclerosis Vaccination for atherosclerosis: a novel therapeutic paradigm.Low-Grade Inflammation, Oxidative Stress and Risk of Invasive Post-Menopausal Breast Cancer - A Nested Case-Control Study from the Malmö Diet and Cancer Cohort.Immune response to lipoproteins in atherosclerosis.Vaccination against T-cell epitopes of native ApoB100 reduces vascular inflammation and disease in a humanized mouse model of atherosclerosis.Immunomodulation of atherosclerosis with a vaccine.An apolipoprotein B100 mimotope prevents obesity in mice.Immunoglobulins against tyrosine-nitrated epitopes in coronary artery disease Autoimmunity in atherosclerosis: a protective response losing control?2015 Russell Ross Memorial Lecture in Vascular Biology: Protective Autoimmunity in Atherosclerosis Antigen-induced immunomodulation in the pathogenesis of atherosclerosis.Associations between autoantibodies against apolipoprotein B-100 peptides and vascular complications in patients with type 2 diabetes Atheroprotective Vaccination with MHC-II Restricted Peptides from ApoB-100.Human IgM Antibodies to Malondialdehyde Conjugated With Albumin Are Negatively Associated With Cardiovascular Disease Among 60-Year-Olds.T-Cells Specific for a Self-Peptide of ApoB-100 Exacerbate Aortic Atheroma in Murine Atherosclerosis.Advances in immune-modulating therapies to treat atherosclerotic cardiovascular diseases Progress and future opportunities in the development of vaccines against atherosclerosis.Adaptive immunity in atherosclerosis: mechanisms and future therapeutic targets.Vaccines against atherosclerosis.Can we vaccinate against atherosclerosis?Atheroprotective immunity and cardiovascular disease: therapeutic opportunities and challenges.The immunology of atherosclerosis.Chlamydomonas reinhardtii chloroplasts express an orally immunogenic protein targeting the p210 epitope implicated in atherosclerosis immunotherapies.Effects of simvastatin on circulating autoantibodies to oxidized LDL antigens: relation with immune stimulation markers.High plasma concentrations of autoantibodies against native peptide 210 of apoB-100 are related to less coronary atherosclerosis and lower risk of myocardial infarction.Autoantibodies against aldehyde-modified collagen type IV are associated with risk of development of myocardial infarction.Decreased levels of autoantibodies against apolipoprotein B-100 antigens are associated with cardiovascular disease in systemic lupus erythematosus.

P2860

Q27025697-DEA20115-2301-4547-976C-A38923B7CFAE Q28732168-0B0498FA-8AF3-4132-BEB4-9ACBDC513803 Q30381851-75245522-969F-43F6-B514-76D575F385AC Q31055400-3D27433E-8C7E-4520-8B57-54F4DDC99B70 Q33641227-7246B0A2-7CF3-4B4E-8474-2741B1566989 Q33770999-DC4E8300-E7C0-408D-82E8-7CB0A530362B Q33839918-211A7677-D090-4EEA-B424-5C7BCD6CADDB Q33930928-9B61BDFF-60DF-4375-AD4B-01996ECAD4F6 Q34188667-B48E3CEA-DF78-432A-893B-D0945BCCD474 Q35175305-E5D233EC-524C-44B0-9B6A-1E41FAC9F564 Q35600876-B1C6AA77-E4BA-4A6D-A366-309A60E3916D Q35987813-FBC67B87-63CD-4BE5-A876-09B527229BA8 Q36071192-230DBC13-9F8E-4F84-883D-3EBEE4EC361A Q36203882-47EAC050-30CA-4576-9256-82C5DA997D0C Q36279562-0AA2FE19-FFB1-4EDF-96AE-CA3653E5020E Q36321769-3E854254-32A4-4172-A5F7-2F9F0F639AE4 Q36357399-8C3644C0-36C6-41BD-B0B5-28FFBEF19CB1 Q36411136-AFCAFBDB-0407-4A38-BD9C-A99296553BC6 Q37138017-8B1D0E3D-F432-4E43-828D-57CFD24F6853 Q37146276-CC1932F5-80A9-4084-9088-EB2881D8685B Q37190468-E0B212BB-A88D-4AE9-8B53-9F7087CDF811 Q37207913-9077FA2C-8A39-4683-957E-42DA6772C51D Q37415733-54EF3346-F780-4231-9AF2-1854D40CEE0C Q37556461-BC26541B-4CF3-43C8-B2EA-2E96D4CD9D2D Q37660865-B96A1CC0-620C-4B89-8F9D-35A3E1FD51E3 Q37709623-DF04F41A-9E28-46CF-A5D5-349D72D43386 Q37835406-0DC627FF-3837-438B-B575-49AC5DC73661 Q37866627-372A93EF-70CB-4C95-8131-3973762FAB82 Q38089941-8EEF96DA-39D4-49AD-ADC0-D85D6D57CC09 Q38137846-48ABBD87-E9E9-49E5-B9D4-B6A2324341A6 Q38346930-853545C1-CEC8-44B1-8BF0-8D626D66A80F Q39230390-829D7E97-10F2-494C-84FC-7EBC2DB7DD34 Q39990498-E87B2E30-3A8D-4C4A-9619-C5E0988BAE12 Q46081322-3D6045A5-838D-43EA-A23D-C15983460D17 Q46457217-A5AC21C2-0B12-4C35-AFF7-576CB9593F9A Q47750132-7C2E5BD4-FCB5-4D46-8C3E-F030D5EC19E5 Q49072554-3A21FCA3-9DA5-47F3-AB60-8A283B64E62B

P2860

Identification of immune responses against aldehyde-modified peptide sequences in apoB associated with cardiovascular disease.

http://www.wikidata.org/entity/Q31135767

description

2003 nî lūn-bûn

@nan

2003 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի մարտին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Identification of immune respo ...... d with cardiovascular disease.

@ast

Identification of immune respo ...... d with cardiovascular disease.

@en

type

label

Identification of immune respo ...... d with cardiovascular disease.

@ast

Identification of immune respo ...... d with cardiovascular disease.

@en

prefLabel

Identification of immune respo ...... d with cardiovascular disease.

@ast

Identification of immune respo ...... d with cardiovascular disease.

@en

P1433

Q31135767-2BC02A94-F95B-4098-9975-8E369BBE7761

P1476

Q31135767-ADB483AE-3760-4BEE-B0BF-10F7CFF16984

P2093

Q31135767-111BBE4B-09DA-4B2E-82EB-BF34D038910A

Q31135767-4C7667B6-6CEF-41D5-B665-7E4060C1C94C

Q31135767-692B4770-34E9-4213-9B65-51342051189A

Q31135767-8A53CBDD-B978-4454-AD50-A073C145C531

Q31135767-A1A25239-84E2-4EF4-B664-532D01740849

Q31135767-CEEBF641-4D8C-42C2-BEDA-33D42F035938

Q31135767-D03F3846-EE17-420B-A864-20E8487473AC

Q31135767-D19BF523-8C16-4278-9D37-AB831E0A4F6F

Q31135767-F133DD17-42C9-40A3-84EB-D1EB2E475426

P304

Q31135767-B683878D-68C9-4B47-A5EE-6834BC9BF3B7

P31

Q31135767-315F51E0-7065-48D8-9D14-00348C365C40

P356

Q31135767-CB8FAC98-E1A7-4A71-B862-F49B6E50E745

P407

Q31135767-64CB7D05-C528-4752-9D15-1252A58AD6B7

P433

Q31135767-F1B668D4-405F-454D-98CC-9EDA9272DFEA

P478

Q31135767-E1AFF562-025E-42BC-B1CF-5B0C2376E8B3

P577

Q31135767-A58880B7-1F75-4FC9-9811-C7506F11676B

P698

Q31135767-38A56EC3-B6F4-4211-A1F6-88EC89851BF9

P921

Q31135767-A40E8A2D-522B-46B3-BDC8-60B06B0096B8

P356

01.ATV.0000067935.02679.B0

P1433

Arteriosclerosis, Thrombosis, and Vascular Biology

P1476

Identification of immune respo ...... d with cardiovascular disease.

@en

P2093

Bo Hedblad

http://www.w3.org/2001/XMLSchema#string

Bojan Cercek

http://www.w3.org/2001/XMLSchema#string

Gunilla Nordin Fredrikson

http://www.w3.org/2001/XMLSchema#string

Göran Berglund

http://www.w3.org/2001/XMLSchema#string

Jan Nilsson

http://www.w3.org/2001/XMLSchema#string

Kuang-Yuh Chyu

http://www.w3.org/2001/XMLSchema#string

Mikko Ares

http://www.w3.org/2001/XMLSchema#string

Prediman K Shah

http://www.w3.org/2001/XMLSchema#string

Ragnar Alm

http://www.w3.org/2001/XMLSchema#string

P304

872-878

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/01.ATV.0000067935.02679.B0

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P577

2003-03-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12649091

http://www.w3.org/2001/XMLSchema#string

P921

cardiovascular disease